AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MyCelx Technologies Corporation

Transaction in Own Shares May 21, 2025

10837_dirs_2025-05-21_a69041f7-e030-43a1-a233-6a1d5f61aa6c.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6532J

MyCelx Technologies Corporation

21 May 2025

21 May 2025

MYCELX Technologies Corporation

("MYCELX" or the "Company" (AIM: MYX)

Director Dealing

The Company announces that it was notified by Connie Mixon , Chief Executive Officer and Director of the Company, that on 21 May 2025, she purchased 73,500 common shares in the Company of US$0.025 each ("Common Shares"), at a price of £0.26415 per Common Share. Following this transaction, Mrs. Mixon holds 2,776,068 Common Shares representing 11.39 per cent of the total issued capital of the Company. In addition, the spouse of Mrs. Mixon also holds 229,008 shares in the Company.

For further information please contact:

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO
Tel: +1 888 306 6843
Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

Giles Balleny (Corporate Finance)

Jamie Anderson (Corporate Broking)

Jasper Berry / Michael Johnson (Sales)
Tel: +44 20 7523 8000
Celicourt Communications (Financial PR)

Mark Antelme

Jimmy Lea

Charlie Denley-Myerson
Tel: +44 20 2770 6424

Notification of transactions of persons discharging managerial responsibility or connected persons

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

C onnie Mixon

2

Reason for the notification

a)

Position/status

Chief Executive Officer and Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MYCELX Technologies Corporation

b)

LEI

213800UJZINIK2VD1G48

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Common shares of US$0.025

ISIN: US62847T2024

b)

Nature of the transaction

Purchase of Common Shares in GBP

c)

Price(s) and volume(s)

Price(s) Volume(s)
£0.26415 73,500

d)

Aggregated information

- Aggregated volume

- Price

n/a

n/a

e)

Date of the transaction

21/05/2025

f)

Place of the transaction

London Stock Exchange (AIM)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFFSEVILFIE

Talk to a Data Expert

Have a question? We'll get back to you promptly.